Ligand validation:2VSU

ACO: ACETYL COENZYME *A

ACO is a Ligand Of Interest in 2VSU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VSU_ACO_E_1250	73%	34%	0.13	0.957	1.23	1.49	4	10	0	0	100%	0.9804
2VSU_ACO_B_1251	73%	36%	0.137	0.964	1.15	1.43	3	8	0	0	100%	1
2VSU_ACO_D_1250	64%	32%	0.157	0.958	1.4	1.42	4	9	7	0	100%	0.9902
2VSU_ACO_F_1249	63%	31%	0.148	0.944	1.43	1.44	6	7	0	0	100%	0.9804
2VSU_ACO_A_1250	33%	39%	0.172	0.851	1.15	1.29	4	5	2	0	100%	0.5196
2VSS_ACO_B_1251	62%	31%	0.169	0.964	1.22	1.61	5	11	0	0	100%	1
3R96_ACO_B_400	99%	54%	0.056	0.985	0.72	1.04	-	3	0	0	100%	1
4B5O_ACO_A_1197	99%	50%	0.065	0.993	1.05	0.87	4	-	0	0	100%	1
5LS7_ACO_B_203	98%	37%	0.059	0.983	1.07	1.48	3	10	0	0	100%	1
3TE4_ACO_A_231	98%	44%	0.059	0.98	0.97	1.25	2	6	0	0	100%	1
4IF5_ACO_A_201	98%	20%	0.064	0.983	2.35	1.19	12	6	1	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.